The Investor Relations website contains information about Ayala Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
January 12, 2023, Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer.
Advaxis Reports Fiscal Year 2021 Financial Results and Provides a Business Update ... (Nasdaq: ADXS) (“Advaxis ... Investor Relations. ir@ayalapharma.com. Questions.
Get the latest insights on Advaxis Inc. (ADXS) with press releases and corporate news to help you in your trading and investing decisions.
Find the latest Ayala Pharmaceuticals, Inc. (ADXS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: investor relations
... financial statements included in our Annual Report on Form 10-K. In addition, we intend to use our media and investor relations website (www.advaxis.com/ ...
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
A high-level overview of Ayala Pharmaceuticals, Inc. (ADXS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...
Missing: relations | Show results with:relations
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement
ayalapharma.gcs-web.com › event-details
Ayala Pharmaceuticals and Advaxis Enter into Merger Agreement. October 19, 2022 8:00 AM EDT. Webcast. Ayala - Investor Tools ... Investor Relations. ir@ ...
Sep 3, 2020 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations